company background image
CVS logo

CVS Health NYSE:CVS Rapporto sulle azioni

Ultimo prezzo

US$57.74

Cap. di mercato

US$73.4b

7D

0.3%

1Y

-13.2%

Aggiornato

22 Aug, 2024

Dati

Dati finanziari dell'azienda +

CVS Health Corporation

NYSE:CVS Rapporto sulle azioni

Cap. di mercato: US$73.4b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Community Narratives

Narratives bring a range of perspectives from our community.

US$69.10
FV
16.4% undervalued intrinsic discount
4.99%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 1 month agoauthor updated this narrative
JU
julio
Community Contributor

CVS VALUATION

US$63.33
FV
8.8% undervalued intrinsic discount
9.19%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 2 months agoauthor updated this narrative

CVS Health Corporation Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per CVS Health
Prezzi storici delle azioni
Prezzo attuale dell'azioneUS$57.74
Massimo di 52 settimaneUS$83.25
Minimo di 52 settimaneUS$52.77
Beta0.51
1Variazione di 1 mese-0.40%
Variazione a 3 mesi3.96%
Variazione di 1 anno-13.16%
3Variazione a 3 anni-30.46%
Variazione a 5 anni-4.01%
Variazione dall'IPO8,694.83%

Notizie e aggiornamenti recenti

A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

Aug 08
A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run

Aug 07

Recent updates

A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

Aug 08
A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run

Aug 07

Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

Jul 21
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

CVS Health: A Better Investment Than Walgreens Boots Alliance

Jul 09

Vltava Fund - CVS Health Corp.: Why We Sold CVS

Jul 03

CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell

Jun 21

The Correct Play On CVS Health

Jun 06

CVS Health: Downside Movement Is Overdramatic

May 26

CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity

May 15

We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

CVS Health: A Terrible Earnings Report, But An Undervalued Stock

May 04

CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 03
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot

Apr 22

Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

Apr 14
Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date

Apr 10

Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

Mar 27
Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

CVS Health: Better Times Likely Ahead

Mar 12

CVS Health: Lower Guidance But Risk/Reward Remains Attractive

Feb 15

CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance

Feb 07

CVS Health: Back In The Buy Column

Jan 21

CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

Jan 17
CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength

Jan 08

CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

Jan 03
CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

CVS Health: Risk/Reward Highly Skewed To The Upside

Dec 15

CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

Dec 13
CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

Dec 08
We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

CVS Health: A Good Fit To Buffett's 10x Pretax Rule

Dec 07

Rendimenti per gli azionisti

CVSUS HealthcareUS Mercato
7D0.3%0.5%0.4%
1Y-13.2%13.1%25.3%

Ritorno vs Industria: CVS ha avuto una performance inferiore rispetto al US Healthcare che ha registrato un rendimento 11.5 % nell'ultimo anno.

Rendimento vs Mercato: CVS ha avuto una performance inferiore al mercato US che ha registrato un rendimento 25.6 % nell'ultimo anno.

Volatilità dei prezzi

Is CVS's price volatile compared to industry and market?
CVS volatility
CVS Average Weekly Movement4.4%
Healthcare Industry Average Movement7.1%
Market Average Movement6.3%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.2%

Prezzo delle azioni stabile: CVS non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 4% ) di CVS è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
1996259,500Karen Lynchwww.cvshealth.com

CVS Health Corporation fornisce soluzioni sanitarie negli Stati Uniti. Opera attraverso i segmenti Health Care Benefits, Health Services e Pharmacy & Consumer Wellness. Il segmento Health Care Benefits offre prodotti assicurativi sanitari tradizionali, volontari e diretti ai consumatori e servizi correlati.

CVS Health Corporation Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di CVS Health con la sua capitalizzazione di mercato?
CVS statistiche fondamentali
Capitalizzazione di mercatoUS$73.37b
Guadagni(TTM)US$7.19b
Ricavi(TTM)US$361.86b

10.1x

Rapporto P/E

0.2x

Rapporto P/S

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
CVS Conto economico (TTM)
RicaviUS$361.86b
Costo del fatturatoUS$309.85b
Profitto lordoUS$52.00b
Altre speseUS$44.81b
GuadagniUS$7.19b

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)5.72
Margine lordo14.37%
Margine di profitto netto1.99%
Rapporto debito/patrimonio netto86.5%

Come si è comportato CVS nel lungo periodo?

Vedi performance storica e confronto

Dividendi

4.6%

Rendimento attuale del dividendo

45%

Rapporto di remunerazione